Jim Simons’s LeMaitre Vascular LMAT Stock Holding History

Jim Simons’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.1M	Sell	138,502 -42,000	-23%	-$4M	0.02%	766
2025 Q4	$14.6M	Sell	180,502 -100	-0.1%	-$8.61K	0.02%	749
2025 Q3	$15.8M	Buy	180,602 +21,902	+14%	+$1.96M	0.02%	850
2025 Q2	$13.2M	Buy	158,700 +4,400	+3%	+$368K	0.02%	906
2025 Q1	$12.9M	Sell	154,300 -9,500	-6%	-$884K	0.02%	870
2024 Q4	$15.1M	Buy	163,800 +1,300	+0.8%	+$125K	0.02%	787
2024 Q3	$15.1M	Buy	162,500 +22,400	+16%	+$1.94M	0.02%	822
2024 Q2	$11.5M	Buy	140,100 +4,164	+3%	+$306K	0.02%	842
2024 Q1	$9.02M	Buy	135,936 +21,936	+19%	+$1.35M	0.01%	1045
2023 Q4	$6.47M	Buy	114,000 +22,200	+24%	+$1.16M	0.01%	1194
2023 Q3	$5M	Buy	91,800 +16,100	+21%	+$954K	0.01%	1314
2023 Q2	$5.09M	Buy	75,700 +15,600	+26%	+$952K	0.01%	1424
2023 Q1	$3.09M	Buy	60,100 +7,700	+15%	+$374K	﹤0.01%	1757
2022 Q4	$2.41M	Sell	52,400 -500	-0.9%	-$23.4K	﹤0.01%	1958
2022 Q3	$2.68M	Sell	52,900 -4,100	-7%	-$205K	﹤0.01%	1840
2022 Q2	$2.6M	Sell	57,000 -3,300	-5%	-$148K	﹤0.01%	2005
2022 Q1	$2.8M	Sell	60,300 -6,000	-9%	-$268K	﹤0.01%	1978
2021 Q4	$3.33M	Sell	66,300 -37,200	-36%	-$1.92M	﹤0.01%	1788
2021 Q3	$5.5M	Buy	103,500 +57,261	+124%	+$3.23M	0.01%	1406
2021 Q2	$2.82M	Sell	46,239 -17,261	-27%	-$917K	﹤0.01%	2014
2021 Q1	$3.1M	Sell	63,500 -26,100	-29%	-$1.22M	﹤0.01%	1945
2020 Q4	$3.63M	Buy	+89,600	New	+$3.2M	﹤0.01%	1787
2020 Q3	–	Sell	-29,800	Closed	-$787K	–	3540
2020 Q2	$787K	Sell	29,800 -14,000	-32%	-$366K	﹤0.01%	2668
2020 Q1	$1.09M	Sell	43,800 -22,800	-34%	-$704K	﹤0.01%	2385
2019 Q4	$2.39M	Buy	66,600 +500	+0.8%	+$17.3K	﹤0.01%	2234
2019 Q3	$2.26M	Buy	66,100 +2,500	+4%	+$79.9K	﹤0.01%	2220
2019 Q2	$1.78M	Buy	+63,600	New	+$1.77M	﹤0.01%	2391
2019 Q1	–	Sell	-10,193	Closed	-$241K	–	3590
2018 Q4	$241K	Sell	10,193 -15,207	-60%	-$415K	﹤0.01%	3089
2018 Q3	$984K	Sell	25,400 -37,500	-60%	-$1.35M	﹤0.01%	2608
2018 Q2	$2.11M	Sell	62,900 -44,400	-41%	-$1.58M	﹤0.01%	2238
2018 Q1	$3.89M	Sell	107,300 -49,700	-32%	-$1.72M	﹤0.01%	1985
2017 Q4	$5M	Sell	157,000 -95,600	-38%	-$3.27M	0.01%	1804
2017 Q3	$9.45M	Sell	252,600 -62,000	-20%	-$2.11M	0.01%	1366
2017 Q2	$9.82M	Buy	314,600 +131,300	+72%	+$3.79M	0.01%	1286
2017 Q1	$4.51M	Buy	183,300 +64,200	+54%	+$1.51M	0.01%	1745
2016 Q4	$3.02M	Sell	119,100 -64,400	-35%	-$1.43M	﹤0.01%	1994
2016 Q3	$3.64M	Buy	183,500 +84,200	+85%	+$1.47M	0.01%	1811
2016 Q2	$1.42M	Sell	99,300 -25,300	-20%	-$387K	﹤0.01%	2382
2016 Q1	$1.93M	Buy	124,600 +800	+0.6%	+$11.5K	﹤0.01%	2239
2015 Q4	$2.14M	Buy	123,800 +6,900	+6%	+$99.9K	﹤0.01%	2067
2015 Q3	$1.43M	Buy	116,900 +41,300	+55%	+$530K	﹤0.01%	2198
2015 Q2	$912K	Buy	75,600 +23,000	+44%	+$226K	﹤0.01%	2493
2015 Q1	$441K	Buy	52,600 +9,537	+22%	+$74.8K	﹤0.01%	2648
2014 Q4	$329K	Buy	43,063 +15,663	+57%	+$112K	﹤0.01%	2555
2014 Q3	$189K	Buy	27,400 +7,138	+35%	+$53.3K	﹤0.01%	2563
2014 Q2	$168K	Buy	20,262 +6,984	+53%	+$54.6K	﹤0.01%	2596
2014 Q1	$107K	Buy	+13,278	New	+$106K	﹤0.01%	2693

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jim Simons's LMAT Position: Q1 2026 in Review

Jim Simons reduced its LeMaitre Vascular (LMAT) stake by 23% in Q1 2026, selling an estimated $4M and leaving 138,502 shares worth $15.1M. The position accounts for 0.02% of the portfolio, ranked #766.

Jim Simons first reported a position in LMAT in Q1 2014 and has held it in 47 quarters since. The position peaked at $15.8M in Q3 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Jim Simons held 138,502 shares of LeMaitre Vascular worth $15.1M as of Q1 2026.
Jim Simons sold 42,000 LeMaitre Vascular shares in Q1 2026, an estimated $4M.
LeMaitre Vascular made up 0.02% of Jim Simons's portfolio in Q1 2026, its #766 holding.
Jim Simons first reported a position in LeMaitre Vascular in Q1 2014 and has held it in 47 quarters since.
Jim Simons's LeMaitre Vascular position peaked at $15.8M in Q3 2025.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.